Psychiatric NP Scope of Practice for Anxiety

If you’re a psychiatrist or PMHNP treating anxiety via telehealth, you’re navigating one of the most dynamic regulatory environments in mental health. The rules around prescribing anxiety medications remotely — especially controlled substances like benzodiazepines — have shifted dramatically since 2020, and they’re still evolving.

Here’s what’s actually happening with telehealth prescribing regulations in 2025, and what it means for your practice.

Federal DEA Rules: Extended Again, But For How Long?

The bottom line first: As of February 2026, you can still prescribe controlled substances for anxiety (including benzodiazepines) via telehealth without an initial in-person exam. The DEA extended COVID-era flexibilities through December 31, 2025, and that extension remains in effect.

Under normal circumstances, the Ryan Haight Act requires an in-person medical evaluation before prescribing any controlled substance ‘by means of the Internet.’ That would have made it illegal to start a patient on Xanax or Klonopin after just a video visit. But the public health emergency exception — invoked in March 2020 — changed everything.

The DEA has now extended these telehealth prescribing flexibilities three times. Each extension came after intense pushback from the mental health community. In 2023, when the DEA proposed reinstating in-person requirements (with only a 30-day telehealth allowance), over 38,000 public comments poured in opposing the restrictions.

So the DEA backed off and announced they’re working on a ‘new path forward for telemedicine.’ Translation: expect permanent rules eventually, but no one knows exactly what they’ll look like.

What this means for your practice:

• You can legally e-prescribe benzodiazepines after a telehealth evaluation through at least the end of 2025
• Document your telehealth encounters thoroughly — video exams, clinical justification, standard of care
• Have a contingency plan if rules change in 2026 (hybrid care models, affiliate clinic arrangements, etc.)
• Stay registered: you still need your DEA number and state-specific controlled substance licenses where required

The uncertainty is frustrating, but it’s the reality. Build flexibility into your practice model.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Prescribing Rules: Where Geography Really Matters

Federal DEA rules set the floor, but each state adds its own layer of telehealth and prescribing regulations. For anxiety providers, this creates a patchwork you need to navigate carefully.

California: Telehealth-Friendly, License-Strict

California doesn’t require an in-person exam before prescribing via telehealth, as long as you meet the standard of care through your telehealth evaluation. That’s actually quite permissive — even asynchronous methods (questionnaires, secure messaging) can be part of establishing care if clinically appropriate.

Key compliance points:

• Must have a CA medical license (no special telehealth license; California isn’t in the Interstate Medical Licensure Compact)
• Mandatory e-prescribing for all prescriptions, including anxiety meds
• CURES PDMP check required before prescribing Schedule II–IV controlled substances, and at least every 4 months for ongoing therapy
• NP independence coming: By 2026, experienced PMHNPs in California can practice fully independently under AB 890 — no physician oversight required

California’s main barrier isn’t telehealth rules; it’s the licensing requirement. If you want to treat California patients remotely, you need to go through the full CA licensure process (or already have one).

Texas: Video Required, Schedule II Limits for NPs

Texas modernized its telehealth laws in 2017, removing the old in-person requirement. You can establish a physician-patient relationship via synchronous audio-video telemedicine and prescribe from that first visit.

Texas-specific rules:

• Real-time video required for new patient evaluations (audio-only won’t cut it for initial controlled substance prescribing)
• Chronic pain exception: You cannot prescribe Schedule II controlled substances for chronic pain management via telemedicine (doesn’t affect anxiety treatment, which is psychiatric)
• Mandatory PDMP checks: Texas requires checking the state Prescription Monitoring Program before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol
• NP restrictions: Texas APRNs cannot prescribe Schedule II drugs in outpatient settings except in hospitals or hospice care — they need physician collaboration for all prescribing, and Schedule II (like Adderall for comorbid ADHD) is off-limits

If you’re a psychiatrist in Texas, you have full prescribing authority. If you’re a PMHNP, you’re working under a Prescriptive Authority Agreement with a physician and you cannot prescribe stimulants or other Schedule II medications for outpatient anxiety/ADHD patients.

Florida: Psychiatric Treatment Exception for Schedule II

Florida has explicit telehealth controlled substance rules with a specific carve-out for psychiatry. Normally, Florida prohibits prescribing Schedule II controlled substances via telehealth — but there are four exceptions, and ‘treatment of a psychiatric disorder’ is one of them.

What this means:

• Psychiatrists can prescribe Schedule II medications (like Adderall for comorbid ADHD/anxiety) via telehealth if it’s for a mental health condition
• PMHNPs face a 7-day limit on Schedule II prescriptions unless they’re certified psychiatric nurses treating mental illness (then the limit doesn’t apply)
• E-FORCSE PDMP check required before prescribing any Schedule II–V controlled substance and every 90 days thereafter
• Patient consent for telehealth must be obtained and documented
• Out-of-state providers: Florida offers a special Telehealth Provider Registration so you can treat Florida patients without a full FL license (one of the few states with this option)

For anxiety treatment, most medications are Schedule IV (benzodiazepines) or non-controlled, so Florida’s Schedule II restrictions rarely come up. But the PDMP and consent requirements apply to all telehealth controlled substance prescribing.

New York: Strict PDMP, NP Independence

New York doesn’t restrict telehealth prescribing beyond federal law, but it has one of the strictest prescription monitoring requirements in the country.

New York specifics:

• I-STOP mandate: Prescribers must check the state PMP registry before every Schedule II, III, or IV prescription — not just the first one, every single time
• Mandatory e-prescribing for all medications (since 2016)
• NP full practice authority: Experienced PMHNPs (3,600+ hours of practice) can practice independently without physician collaboration as of 2022
• No special telehealth license — you need a full NY medical license (NY isn’t in the IMLC)

That I-STOP requirement is significant. If you’re refilling a patient’s Klonopin prescription, you’re legally required to log into the PMP system first. Build this into your workflow — many EHRs integrate PMP access now.

Pennsylvania: PDMP for Every Benzo Prescription

Pennsylvania requires PDMP checks specifically for benzodiazepines and opioids — not just once, but each time you prescribe them.

Key Pennsylvania rules:

• PDMP check required before the initial prescription of any benzodiazepine or opioid and before each subsequent refill (per Act 191)
• E-prescribing mandatory for controlled substances (since 2019)
• NP collaborative agreements required: PMHNPs must have a written agreement with a physician; Schedule II prescriptions limited to 30-day supply, Schedule III–IV to 90-day supply
• IMLC member: Pennsylvania participates in the Interstate Medical Licensure Compact, making multi-state licensing easier for psychiatrists

The PDMP check-every-time requirement for benzodiazepines makes Pennsylvania one of the more stringent states for anxiety medication management. This was enacted as part of the state’s opioid crisis response but specifically includes benzos due to overdose risks when combined with opioids.

Illinois: NP Independence with a Twist

Illinois allows full practice authority for experienced PMHNPs, but with a unique controlled substance consultation requirement.

Illinois details:

• Full Practice Authority available: APRNs with 4,000+ hours and additional training can practice independently
• Special consult rule: NPs with FPA who prescribe Schedule II narcotics (opioids) must have a physician consultation relationship for the first 5 years — but this doesn’t apply to non-narcotic Schedule IIs or Schedule III–V drugs like benzodiazepines
• Audio-only telehealth permitted for mental health services when video isn’t available
• State controlled substance license required in addition to DEA registration
• IMLC member for physician licensing

Illinois is relatively progressive for NP practice. An experienced PMHNP with FPA in Illinois can independently prescribe benzodiazepines for anxiety via telehealth without physician oversight.

Psychiatrist vs PMHNP Scope: What’s Actually Different?

Psychiatrists: Full Authority, No Restrictions

As a psychiatrist (MD or DO), you have independent practice authority in every state. No supervision required, no collaborative agreements, no prescribing formulary limits beyond standard medical board oversight.

You can:

• Diagnose any anxiety disorder
• Prescribe any medication (controlled or not) within accepted standards of care
• Practice and prescribe independently via telehealth in any state where you’re licensed
• Combine medication management with psychotherapy (though time constraints often limit this)

Your regulatory challenges aren’t scope limitations — they’re licensing (getting credentials in multiple states) and prescribing compliance (PDMP checks, e-prescribing, DEA registration).

PMHNPs: Full Capability, Variable Independence

As a PMHNP, you can assess, diagnose, and treat anxiety disorders in every state. You can prescribe anxiety medications including controlled substances. But how independently you practice depends entirely on your state.

Full practice states (for experienced NPs):

• New York (after 3,600 hours)
• Illinois (after 4,000 hours with FPA)
• California (phasing in through 2026)

In these states, you evaluate patients, prescribe medications (including benzodiazepines), and manage treatment on your own authority.

Restricted practice states:

• Texas (prescriptive authority agreement required; no Schedule II in outpatient settings)
• Florida (supervisory protocol required; 7-day Schedule II limit for non-psychiatric specialists)
• Pennsylvania (collaborative agreement required; 30-day Schedule II, 90-day Schedule III–IV limits)

In these states, you’re working under a physician’s oversight with defined prescribing parameters.

Controlled substance prescribing differences:

• All PMHNPs can prescribe Schedule IV benzodiazepines (with appropriate authority)
• Schedule II restrictions vary: Texas NPs can’t prescribe them outpatient at all; Florida psychiatric NPs can for mental health; Pennsylvania NPs limited to 30-day supply
• Every state requires NPs to have DEA registration plus any state-specific controlled substance license

For telehealth platforms, this means the infrastructure must adapt state-by-state. Klarity and similar services ensure physician collaborators are available in restricted-practice states so PMHNPs can legally prescribe.

The Economics of Telehealth Anxiety Practice

Let’s talk about what this actually means for building a sustainable practice.

If you’re considering DIY patient acquisition (SEO, Google Ads, directory listings), understand the real numbers. Acquiring a qualified psychiatric patient through independent marketing typically costs $200–500+ per patient when you factor in:

• Agency or consultant fees (SEO firms charge $2,000–5,000/month)
• Google Ads testing and optimization (mental health keywords run $15–40+ per click; most clicks don’t convert)
• Staff time to handle and qualify leads
• No-show rates from cold leads (higher than platform-matched patients)
• 6–12 months of SEO investment before meaningful results
• Failed campaigns and wasted spend

Directory listings (Psychology Today, Zocdoc) seem cheaper but add up. You’re paying monthly subscription fees AND competing with hundreds of other providers on the same page. Zocdoc charges per booking ($35–100+), but your total monthly cost including the subscription fee often exceeds $500–1,000 even with modest patient volume.

The platform model (like Klarity) changes the economics entirely:

• No upfront marketing spend or monthly subscription fees
• Pay only when a pre-qualified patient books with you (similar to Zocdoc’s per-booking model)
• Patients are already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule and only pay for actual appointments

Instead of spending $3,000–5,000/month on marketing with uncertain ROI, you pay a standard fee per new patient lead. That’s guaranteed ROI versus gambling on marketing channels you may not have the expertise or time to optimize.

For most providers — especially those starting out or scaling — this removes the risk entirely while you build your practice. Once you have steady patient volume and cash flow, you can always add DIY marketing channels if you want additional patient sources.

Compliance Best Practices for Telehealth Anxiety Treatment

Regardless of state or provider type, follow these practices to stay compliant:

1. Document the telehealth encounter thoroughly

• Note that the visit was conducted via telemedicine
• Document the patient’s location (for state licensing compliance)
• Include a mental status examination (observable via video)
• Record clinical justification for any controlled substance prescription

2. Meet PDMP requirements

• Know your state’s specific rules (every time in PA/NY, every 4 months in CA, before prescribing in TX, etc.)
• Integrate PMP checks into your workflow (most EHRs now have direct access)
• Document when you checked and any relevant findings

3. Use appropriate technology

• Real-time video for initial evaluations (required in most states)
• HIPAA-compliant platforms (Zoom for Healthcare, Doxy.me, etc.)
• DEA-compliant e-prescribing system with two-factor authentication for controlled substances

4. Obtain informed consent

• Explain how telehealth works and its limitations
• Document consent in the medical record
• Some states (Florida, Illinois) explicitly require this

5. Maintain proper licensing

• Be licensed in every state where your patients are located
• Keep DEA registration and state controlled substance licenses current
• For NPs in restricted states, ensure collaborative agreements are properly filed and up-to-date

6. Have emergency protocols

• Know how to connect patients to local crisis services
• Maintain updated emergency contact information
• Document your emergency plan in the medical record

What’s Next: Preparing for Regulatory Changes

The telehealth prescribing landscape will continue evolving. Here’s how to stay ahead:

Short-term (2025):

• Current DEA flexibilities remain through end of year
• Continue prescribing controlled substances via telehealth as you have been
• Monitor DEA announcements for any new proposed rules

Medium-term (2026–2027):

• Expect DEA to finalize permanent telemedicine prescribing rules
• Likely outcome: some form of hybrid requirement (initial telehealth allowed, but in-person assessment required within a certain timeframe for continued controlled substance prescribing)
• California NP independence fully implemented (2026)
• Possible state-level changes as more states move toward NP full practice authority

Long-term strategy:

• Build relationships with local clinics or facilities for in-person assessments if needed
• Diversify your practice across multiple states to reduce dependence on any one state’s rules
• Consider joining platforms that handle compliance infrastructure state-by-state
• Stay connected to professional organizations (APA, AANP) for regulatory updates

The Bottom Line

Telehealth prescribing for anxiety is legal, effective, and here to stay — but the regulatory framework is complex and state-specific. As a psychiatrist, you have full prescribing authority but must navigate multi-state licensing and PDMP requirements. As a PMHNP, your independence varies dramatically by state, from full autonomy to physician-supervised practice.

The federal DEA rules remain permissive through 2025, but permanent regulations are coming. Plan accordingly.

For most providers, the smartest move is partnering with a platform that handles the compliance heavy lifting while you focus on patient care. Whether you’re building a solo telehealth practice or joining an established network, understanding these regulations isn’t optional — it’s the foundation of practicing legally and sustainably.

Ready to practice telehealth anxiety treatment without the compliance headaches? Klarity Health provides the infrastructure, patient flow, and state-by-state compliance support so you can focus on what you do best: helping patients manage their anxiety. Explore how our platform works for psychiatrists and PMHNPs.

Frequently Asked Questions

Can I prescribe benzodiazepines via telehealth in 2025?

Yes, under current DEA rules extended through December 31, 2025, you can prescribe Schedule II–V controlled substances (including benzodiazepines for anxiety) via telehealth without an initial in-person exam. You must conduct an appropriate evaluation via live video, comply with state laws, and maintain proper DEA registration and state licensing.

Do I need an in-person visit before prescribing anxiety medications via telehealth?

For non-controlled anxiety medications (SSRIs, SNRIs, buspirone), no in-person visit is required in any state as long as you meet the standard of care via telehealth. For controlled substances like benzodiazepines, current federal rules don’t require in-person exams (through 2025), though this may change when the DEA issues permanent regulations.

What’s the difference between psychiatrist and PMHNP prescribing authority?

Psychiatrists have independent prescribing authority in all states with no supervision required. PMHNPs can prescribe in all states but may need physician collaboration agreements (Texas, Florida, Pennsylvania) or can practice independently after meeting experience requirements (New York after 3,600 hours, Illinois after 4,000 hours). Some states restrict NP Schedule II prescribing (Texas prohibits it in outpatient settings; Florida limits it to 7 days unless treating psychiatric conditions).

Which states require PDMP checks for benzodiazepine prescriptions?

All six priority states require PDMP checks, but frequency varies: New York requires checking before every Schedule II–IV prescription; Pennsylvania requires checking before each benzodiazepine prescription; California requires checking initially and at least every 4 months; Texas requires checking before prescribing benzos, opioids, barbiturates, or carisoprodol; Florida requires checking before any controlled substance and every 90 days; Illinois strongly encourages checking for all controlled substances.

Can I treat patients in multiple states via telehealth?

Yes, but you must be licensed in each state where your patients are located. The Interstate Medical Licensure Compact (IMLC) can expedite licensing for physicians in member states (Texas, Florida, Pennsylvania, Illinois — but not California or New York). PMHNPs need state-specific APRN licensure or authorization. Some states offer telehealth-specific registrations (Florida) but most require full licensure.

What happens if DEA telehealth rules change in 2026?

The DEA is developing permanent telemedicine prescribing regulations to replace current temporary flexibilities. Likely scenarios include requiring an in-person exam within a certain timeframe (30–90 days) after initiating controlled substance treatment via telehealth, or implementing the special telemedicine DEA registration process outlined in the Ryan Haight Act. Providers should prepare contingency plans including hybrid care models or affiliate clinic arrangements.

References & Sources

1. DEA & HHS Telemedicine Extension (November 15, 2024) – Drug Enforcement Administration official announcement extending telehealth prescribing flexibilities for controlled substances through December 31, 2025. www.dea.gov

2. Ryan Haight Act Provisions – 21 U.S.C. § 829(e) and § 802(54) establishing federal requirements for prescribing controlled substances via Internet/telemedicine, including public health emergency exceptions. www.cchpca.org

3. Florida Statutes on Telehealth – F.S. 456.47 (Telehealth Services) and F.S. 464.012 (APRN controlled substance prescribing), including psychiatric treatment exception for Schedule II telehealth prescribing. www.flsenate.gov and www.leg.state.fl.us

4. Texas APRN Prescriptive Authority – Texas Board of Nursing FAQ clarifying that APRNs may only prescribe Schedule II drugs in hospital-based practice or hospice/palliative care settings, not outpatient practice. www.bon.texas.gov

5. New York I-STOP/PDMP Requirements – New York State Department of Health guidance on mandatory PMP consultation before prescribing Schedule II–IV controlled substances, effective August 27, 2013. healthweb-back.health.ny.gov

Source:

• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=forward%20for%20telemedicine%2C%20DEA%20and,through%20the%20end%20of%202024
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Controlled%20Substance%20Act
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Note%20that%20the%20practice%20of,chapter%205%20of%20title%205
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,services%20within%20the%20applicable%20scope
• https://healthweb-back.health.ny.gov/professionals/narcotic/prescription_monitoring/#:~:text=Effective%20August%2027%2C%202013%2C%20most,to%20view%20dispensed%20controlled%20substance
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=may%20prescribe%20Schedule%20II%20drugs%3F,care%20from%20a%20qualified%20hospice
• https://www.leg.state.fl.us/Statutes/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=893.03%20to%20a%207,formulary%20which%20it%20finds%20is
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Additionally%2C%20the%20rule%20shall%20state,addiction%20medicine%2C%20or%20palliative%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=The%20Attorney%20General%20may%20issue,application%20for%20such%20special%20registration%E2%80%94